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osting by EAbstract We described herein the synthesis of bis-1,3,4-oxadiazole containing glycine moiety. N-
{5-[5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-yl-sulfanyl]-1,3,4-oxadiazole-2-yl-methyl}-4-methoxy-
benzamide was fully characterized by elemental analysis, FT-IR and 1H NMR spectroscopy. Also
this study was designed to show the effects of bis-oxadiazole compound on the activities of some
transferase enzymes such as: GOT, GPT and c-GT in sera. This compound demonstrated activation
on GOT and GPT activities, inhibitory effects on the c-GT activity. These effects increased with
increasing the concentration of the compound. The causes of the increases and decreases in the
enzymes activities are discussed.
ª 2010 King Saud University. All rights reserved.1. Introduction
Derivatives of 1,3,4-oxadiazole constitute an important family
of heterocyclic compounds (Hill, 1984). Substituted 1,3,4-oxa-
diazole are of considerable pharmaceutical and material inter-
est, which is documented by a steadily increasing number of01965123.
(I.H.R. Tomi).
ity. All rights reserved. Peer-
d University.
lsevierpublications and patents (Kartitzky et al., 1995–2007).
Reported among these activities were: nervous system depress-
ing (Maillard et al., 1962), muscle relaxants (Vousooghi et al.,
2007), analgesic (Mishra et al., 1995), herbicidal (Kennedy and
Summers, 1981), hypoglycemic (Girges and Arzneim-Forsch,
1994), antifungal (Xia et al., 2002), anti-inﬂammatory (Suman
and Bahel, 1979) and antibacterial activities (Tashfeen et al.,
2005). In addition to that, derivatives of 1,3,4-oxadiazole are
used in agriculture (Hodogaya, 1980), photosensitizer (Jai
et al., 1999) and liquid crystals (Parra et al., 2006).
Also, the derivatives of heterocyclic compounds were stud-
ied to show their effects on activities of some transferase en-
zymes. Dere and Polat (2001) were studied the biochemical
analysis of (PQ) (1,1-dimethyl-4,40-bipiridillium) on some
transferase enzymes and they found some changes (increases
or decreases) in these enzymes activities.
24 I.H.R. Tomi et al.In view of the importance of transferase enzymes reactions
like GOT, GPT and GGT which form links between the
metabolism of amino acids, carbohydrates and fats.
Glutamate oxaloacetate transaminase (GOT) Enzyme EC
2.6.1.1: it is called also aspartate amino transfer (AST), it is
one of the most important of transferase enzymes, catalyzes
the transfer of the amino group of aspartate to a-ketoglutar-
ate. GOT is widely distributed in human tissues; heart, liver,
skeletal muscle and kidney. The optimum conditions of maxi-
mum enzyme activity are pH 7.4 and temperature = 37 C.
The enzyme stability 3 days in 25 C, 1 week in 5 C and
1 month in 25 C. The clinical usefulness of the enzyme is lar-
gely restricted to the diagnosis of heart and liver diseases.
Large amount of GOT may be released in to the blood. Very
high levels are observed in acute liver disease while lesser ele-
vation is seen in chronic liver disease.
Glutamate pyruvate transaminase (GPT) Enzyme EC
2.6.1.2: it is also called alanine amino transferase (ALT)
which is prevalent in mammalian tissue catalyzes the transfer
of the amino group of alanine to a-ketoglutarate. GPT found
in a highest concentration in livers in spite of its active occur-
rence in skeletal muscles, heart and kidneys. The GPT activ-
ity in tissues is generally less than GOT. GPT level found to
increase in the following diseases; infection hepatitis, liver cir-
rhosis and biliary cirrhosis, obstructive jaundice and liver
cancer.
Gamma glutamate transferase (c-GT) Enzyme EC 2.3.2.2:
it is also called gamma glutamate transpeptides (c-GT) or
(GGT), it is found in kidneys and liver and catalyzes the trans-
fer of gamma-glutamyl group from glutathione to an amino
acid. GGT levels are increased in most forms of liver disease,
especially cholestasis. GGT, a plasma membrane-bound en-
zyme, provides the only activity capable to effect the hydroly-
sis of extra cellular glutathione (GSH), thus favoring the
cellular utilization of its constituent amino acids.
The common synthetic approaches to oxadiazoles involve
cyclization of diacylhydrazines (Georg, 2006). A variety of
reaction conditions inﬂuence the cyclization reaction. Typi-
cally, the reaction is promoted by heat and anhydrous reagents
including thionyl chloride (Al-Talib et al., 1990), phosphorous
oxychloride (Theocharis and Alexandrou, 1990), phosphorous
pentoxide (Carlsen and Jorgensen, 1994), triphenylphosphine
(Brown et al., 1997) and triﬂic anhydride (Liras et al., 2000).
Also Feray et al. (2002) are synthesized the oxadiazole deriva-
tives using the synthetic procedure based on the ring closure
reactions of appropriate acid hydrazides with carbon disulﬁde
in alkali media.
In the literature, we did not found any studies of the effect
of oxadiazole derivatives on the activity of transferase en-
zymes. So, we studied here the effective of bis-1,3,4-oxadiazole
compound containing sulfur atom between the two oxadiazole
rings derived from N-protected glycine attached at C-5 of the
oxadiazole ring, on the activities of some transferase enzymes
such as; aspartate amino transferase (AST), alanine amino
transferase (ALT) and gamma glutamate transferase (c-GT)
in sera. This product might be potential compound for biolog-
ical activity tests on transferase enzymes. A literature search
revealed that no such oxadiazoles derived from amino acids
have yet been prepared except Sebastiao et al. (1998)
synthesized some 3-aryl-1,2,4-oxadiazoles carrying protected
L-alanine side chain.2. Experimental
2.1. Materials and physical measurements
All starting materials and solvents were purchased from
Aldrich and Fluka and used without further puriﬁcation. Melt-
ing points were determined on electrothermal capillary appara-
tus and are uncorrected, elemental analysis (C, H, N) were
carried out using a Perkin-Elmer model 2400 instrument,
FT-IR measurements were recorded on Shimadzu model
FTIR-8400S. 1H NMR spectra were obtained with Bruker
spectrophotometer model ultra shield at 300 MHz in DMSO-
d6 solution with the TMS as internal standard. Note: in some
1H NMR spectra, the peaks at d 2.5 and 3.35 are for the sol-
vent (DMSO-d6) and dissolved water in (DMSO-d6)
respectively.
2.2. Materials and methods of biological activity section
2.2.1. Effect of compound (7) on GOT and GPT activities
Colorimetric determination of GOT or GPT activity according
to the following reactions:
l-Aspartateþ a-ketoglutrate !GOTOxaloaceticþ glutamate
Alanineþ a-ketoglutarate !GPT Pyruvateþ glutmate
The pyruvate or oxaloacetate formed was measured in its
derived from 2,4-dinitrophenylhydrazine, which was absorbed
at wave length 505 nm (Reitman and Frankel, 1957).
2.2.2. Effect of compound (7) on c-GT activity:
Kinetic colorimetric method for the determination of c-GT
activity was assayed by Persijn and Van Der Slik (1976). The
principle of the method was measurement of the 5-amino-2-
nitro benzoate form from reaction, which was absorbed at
wave length 405 nm
l-c-glutamyl-3-carboxy-4-nitroanilideþglycylglycine
!c-GTl-c-glutamyl-glycylglycineþ5-amino-2-nitro-benzoate:2.2.3. A stock solution (0.01 M) of compound (7)
A stock solution (0.01 M) of compound (7) was prepared by
dissolving it in ethanol/DMSO (10/1), and the following con-
centrations (102, 103, 104, 105 M) were prepared by dilut-
ing with absolute ethanol. The enzymes GOT, GPT and GGT
activities were measured in human serum by using the same
methods of these enzymes with replace 100 ll of buffer with
100 ll of compound (7). The inhibition percentage was calcu-
lated by comparing the activity with and without the com-
pound (7) and under the same conditions, according to the
equation:
% Inhibition
¼ 100 100 ðThe activity in the presence of inhibitorÞ=
ðThe activity in the absence of inhibitorÞ
The activation percentage was calculated by comparing the
activity with and without the activator and under the same
conditions, according to the equation:
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¼ 100 ðThe activity in the presence of activatorÞ=
ðThe activity in the absence of activatorÞ  100:2.2.4. A constant concentration of compound (7) (102 M)
A constant concentration of compound (7) (102 M) was used
with different substrate concentrations of (40, 80, 120, 160,
200) mmol/L for GOT and GPT, and (0.4, 0.8, 1.2,
1.62) mmol/L for c-GT, to study the type of inhibition or acti-
vation. Buffers were used to prepared different substrates con-
centrations of these enzymes, GOT, GPT (phosphate buffer
pH = 7.40, 100 mmol/L) and c-GT (TRIS buffer pH = 8.25,
100 mmol/L). The enzymes activities were determined with
and without compound (7), by using the Linweaver and Burke
(1934) equation and plotting 1/v against 1/[s] were evaluated
values; Ki, apparent Vmax (Vmapp), apparent Km (Kmapp), type
of inhibition or activation.
2.3. Preparation methods and physical data of synthesized
compounds (1–7)
2.3.1. 4-Methoxymethyl benzoate (1)
This compound was prepared following the procedure de-
scribed by Brian et al. (1989). Yield (95%); mp: 49–51 C.
2.3.2. 4-Methoxybenzoyl hydrazine (2)
This compound was prepared following the procedure de-
scribed by Smith (1946). Yield (91%); mp: 135–137 C.
2.3.3. 5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-thione (3)
To a solution of hydrazide 2 (1.66 g, 0.01 mol) in ethanol
(20 mL), potassium hydroxide (0.56 g, 0.01 mol) in water
(5 mL) and carbon disulﬁde (2 mL, 0.03 mol) were added.
The reaction mixture was heated under reﬂux till the evolu-
tion of hydrogen sulﬁde ceased (approximately 5 h), there-
fore, it was cooled, diluted with cold water (30 mL) and
acidiﬁed with 10% hydrochloric acid. The solid that sepa-
rated was collected by ﬁltration, washed with water and
recrystallized from ethanol. Yield (84%); mp: 199–201 C;
FT-IR (KBr disk, cm1) 3217 (NAH), 1616 (C‚N), 1253,
1080 (CAOAC); 1H NMR (DMSO-d6, 300 MHz, d) 14.38–
14.78 (s, br. 1H, NH), 7.79–7.85 (dd, 2H, Ar.H), 7.11–7.16
(dd, 2H, Ar.H), 3.86 (s, 3H, OCH3). Anal. Calc. for
C9H8N2O2S (208 g/mol): C, 51.92; H, 3.85; N, 13.46. Found:
C, 51.88; H, 3.80; N, 13.48%.
2.3.4. 5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-
ethoxycarbonylsulfanyl (4)
Compound 3 (2.08 g, 0.01 mol) in an excess of ethyl chlorofor-
mate (3 mL) was heated under reﬂux for 5 h. After cooling the
residue of ethyl chloroformate was removed under reduced
pressure and the solid residue obtained was recrystallized from
ethanol. Yield (79%); mp: 124–125 C; FT-IR (KBr disk,
cm1) 2980, 2937, 2841 (CAH aliph.), 1773 (C‚O), 1626
(C‚N), 1259, 1078 (CAOAC); 1H NMR (DMSO-d6,
300 MHz, d) 7.88–7.85 (dd, 2H, Ar.H), 7.17–7.14 (dd, 2H,
Ar.H), 4.48–4.41 (q, 2H, OCH2 ), 3.86 (s, 3H, OCH3), 1.38–
1.33 (t, 3H, CH3). Anal. Calc. for C12H12N2O4S (280 g/mol):
C, 51.43; H, 4.29; N, 10.00. Found: C, 51.44; H, 4.32; N,
10.03%.2.3.5. 5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-hydrazine-
carbonylsulfanyl (5)
This compound was prepared by the same method described
for compound 2. Yield (87%); mp: 222–224 C; FT-IR (KBr
disk, cm1) 3316, 3146 (NAH), 2935, 2920, 2851 (CAH aliph.)
1640 (C‚O), 1610 (C‚N), 1255, 1074 (CAOAC); 1H NMR
(DMSO-d6, 300 MHz, d) 13.85–13.75 (s, br. 1H, NH), 7.95–
7.92 (dd, 2H, Ar.H), 7.05–7.02 (dd, 2H, Ar.H), 5.72 (s, 2H,
NH2), 3.78 (s, 3H, OCH3). Anal. Calc. for C10H10N4O3S
(266 g/mol): C, 45.11; H, 3.76; N, 21.05. Found: C, 45.14; H,
3.77; N, 21.08%.
2.3.6. 4-(4-Methoxybenzenesulfonyl)-hippuric acid (6)
Glysine (1.5 g, 0.02 mol) in 1 N sodium hydroxide solution
(20 mL) was cooled at 0–5 C and the cold solution was added
dropwise to a solution of 4-methoxybenzoyl chloride (3.41 g,
0.02 mol) in chloroform (30 mL). The reaction mixture was
continued under stirring for an additional 1 h. The aqueous
layer was separated and acidiﬁed with 2 N hydrochloric acid.
The product 6 was collected by ﬁltration and recrystallized
from ethanol as colorless needles. Yield (83%); mp: 178–
180 C; FT-IR (KBr disk, cm1) 3366 (NAH), 3190–2534
(OAH, carboxylic), 2933, 2847 (CAH aliph.) 1743 (C‚O,
acid), 1625 (C‚O, amide); 1H NMR (DMSO-d6, 300 MHz,
d) 8.65–8.63 (t, 1H, NH), 7.86–7.79 (dd, 2H, Ar.H), 6.98–
6.95 (dd, 2H, Ar.H), 3.86–3.84 (d, 2H, CH2), 3.77 (s, 3H,
OCH3). Anal. Calc. for C10H11N1O4 (209 g/mol): C, 57.41;
H, 5.26; N, 6.69. Found: C, 57.44; H, 5.23; N, 6.72%.
2.3.7. N-{5-[5-(4-Methoxyphenyl)-1,3,4-oxadiazole-2-yl-
sulfanyl]-1,3,4-oxadiazole-2-yl-methyl}-4-methoxybenzamide
(7)
Compound 5 (2.66 g, 0.01 mol) and Compound 6 (2.09 g,
0.01 mol) were reﬂuxed with phosphorous oxychloride
(5 mL) for 24 h. and the reaction mixture was then treated with
ice water carefully and made basic by adding concentrated so-
dium bicarbonate solution. The resulting solid was ﬁltered,
dried and recrystallized by ethanol–DMSO (10/1). Yield
(69%); mp: 193–195 C; FT-IR (KBr disk, cm1) 3362
(NAH), 2920, 2839 (CAH aliph.), 1620 (C‚O, amide), 1610
(C‚N), 1255, 1026 (CAOAC); 1H NMR (DMSO-d6,
300 MHz, d) 8.29–8.22 (t, 1H, NH), 8.17–8.11 (dd, 2H,
Ar.H), 7.88–7.81 (dd, 2H, Ar.H), 7.23–7.18 (dd, 2H, Ar.H),
7.09–7.02 (dd, 2H, Ar.H) 3.87 (s, 3H, OCH3 attached to phe-
nyl-oxadiazole), 3.81 (s, 3H, OCH3 attached to benzamide),
3.79–3.82 (d, 2H, CH2). Anal. Calc. for C20H17N5O5S (439 g/
mol): C, 54.67; H, 3.87; N, 15.94. Found: C, 54.71; H, 3.89;
N, 15.98%.
3. Result and discussion
3.1. Synthesis
The characterization data of all compounds 1–7 are given in
the experimental section. All the newly synthesized compounds
gave satisfactory analysis for the proposed structures, which
were conﬁrmed on the basis of their elemental analysis, FT-
IR and 1H NMR data. Our synthetic strategy is show in
Scheme 1.
The ﬁrst step was begun to convert 4-methoxybenzoic acid
to 4-methoxymethyl benzoate 1 by the standard esteriﬁcation
CH3O COOH CH3O COOCH3
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Scheme 1 Synthesis of compounds (1–7).
26 I.H.R. Tomi et al.method (Brian et al., 1989). 4-Methoxybenzoyl hydrazine 2
was synthesized in good yield from the reaction of ester 1 with
excess of hydrazine hydrate in ethanol. Compound 3 was syn-
thesized by the ring closure reaction of acid hydrazide 2 with
carbon disulﬁde in ethanolic KOH.
The tautomeric equilibrium in compound 3 (3a and 3b) was
investigated both for isolated and for solvated species consid-
ering the solution medium. Tsoleridis et al., 1997 studied the
same equilibrium and he found that the thiol form (3b) is more
stable in the gas phase. However, this is contrary to the known
experimental ﬁnding. On the basis of FT-IR and 1H NMR
data, it is know that 5-(4-methoxyphenyl)-1,3,4-oxadiazole-2-
thione (3a) exist in solution in the thione rather than the thiolFigure 1 1H NMR specform (Horning and Muchowski, 1972). Parallel to experimen-
tal data, the thione tautomer is more stable than thiol in the
solution. The equilibrium is even more favored to wards the
thione because the thione is better solvated than thiol. In the
1H NMR spectrum of compound 3 (Fig. 1), the broad peak
at d 14.38–14.78 of the NH proton was recorded, although it
was very weak. It has been reported that the crystal structure
of compound 3 correspond to the thione form (Ozturk et al.,
2004), but the reaction conditions for the synthesis of com-
pound 4 prove that compound 3 can be in the thiol form
too. Finally, the crystal structure of compound 3 corresponded
to the thione form, but they showed thiol–thione tautomerism
in solution.trum of compound 3.
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NN
O SH
Thiol form (3b)
CH3O
NN
O S
H
Thione form (3a)Figure 2 1H NMR spec
Figure 3 1H NMR specAn attempt to prepare the thio ester of oxadiazole ring 4 bytreatment of compound 3 with an excess of ethyl chlorofor-
mate was successful and the product obtained was identiﬁed
by elemental analysis, FT-IR and 1H NMR, Fig. 2 shows
the 1H NMR spectrum of compound 4. The hydrazide of oxa-
diazole ring 5 was prepared in good yield by the reaction of
containing glycine moiety 27trum of compound 4.
trum of compound 5.
28 I.H.R. Tomi et al.compound 4 with excess of 80% hydrazine hydrate in ethanol.
The peaks at d 5.75 and 13.75 in 1H NMR spectrum (Fig. 3)
are the good evidence to formation oxadiazoles hydrazide 5.
The compound 6 was synthesized by the reaction of 4-
methoxybenzoyl chloride with glycine according to Steiger’sFigure 4 1H NMR spec
Figure 5 1H NMR spec(1944) procedure to afford the corresponding hippuric acid
6. The 1H NMR spectrum of compound 6 was shown in
Fig. 4. The hydrazide of oxadiazole ring 5 and compound 6
could be smoothly cyclicdehydrated by boiling in phosphorus
oxychloride affording the bis oxadiazole 7 in good yield. Thetrum of compound 6.
trum of compound 7.
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Scheme 2 The mechanism steps of formation of compound 7.
Table 1 The effect of different concentrations of compound 7 on the activity of GOT, GPT and c-GT enzymes in human serum.
No. Concentration (M) GOT activity (U/L) Activation (%) GPT activity (U/L) Activation (%) c-GT activity (U/L) Inhibition (%)
1 0 17 0.000 16 0.000 6.545 0.000
2 102 79 364.705 64 300.000 1.303 0.000
3 103 30 76.470 20 25.000 2.618 20.000
4 104 29 70.580 18 12.500 5.236 60.000
5 105 24 41.176 17 6.250 6.545 80.000
Synthesis, characterization and effect of bis-1,3,4-oxadiazole rings containing glycine moiety 291H NMR spectra of this compound was shown in Fig. 5. The
mechanism of dehydration in presence of POCl3 is depicted in
the following steps: (Scheme 2).
3.2. Biological activity of transferase enzymes (GOT, GPT and
GGT)
Molecular structure of compound (7) has:CH3O
NN
O S N N
O CH2 NH
OCH3OThis research addresses investigation of the effects of com-
pound (7) of GOT, GPT and c-GT enzymes. The biochemical
tests revealed that this compound caused inhibitory effects on
c-GT enzyme activity and activatory effects on GOT and GPT
enzymes activities. Table 1 shows the effect of different concen-
trations of compound (7) on the activity of GOT, GPT and c-
GT enzymes in human serum.
The normal value of the GOT and GPT enzyme activities
were (17 and 16 U/L) respectively. The relationship between
compound (7) concentrations versus and the activity of en-
zymes were shown in Fig. 6. These results observed that any
increase in compound concentrations caused increase in per-
centage of activation of enzymes. The greater activation of
compound (7) was demonstrated at concentration 102 M
Figure 6 (a) The relationship between concentration of compound 7 and GOT enzyme activity. (b) The relationship between
concentration of compound 7 and GPT enzyme activity.
Figure 7 (a) The percentage of activation GOT enzyme and
compound 7 concentration. (b) The percentage of activation GPT
enzyme and compound 7 concentration.
Figure 8 (a) The relationship between concentration of com-
pound 7 and GGT enzyme activity. (b) The percentage of
activation GGT enzyme and compound 7 concentration.
30 I.H.R. Tomi et al.
Synthesis, characterization and effect of bis-1,3,4-oxadiazole rings containing glycine moiety 31(364.705%) for GOT and 102 M (300%) for GPT as shown in
Fig. 7.
The normal value of the c-GT enzyme activity was (6.545
U/L). The relationship between compound (7) concentration
versus and the activity of enzyme was shown in Fig. 8(a).
These results observed that any increase in compound concen-
trations caused increase in percentage of inhibition of enzyme.
The greater inhibition of compound (7) was demonstrated at
concentration 105 M (55%) as shown in Fig. 8(b).
Competitive, noncompetitive and uncompetitive inhibition
can be easily distinguished with the use of double reciprocal
plot of the Lineweaver–Burk plot. Two sets of rate determina-
tion in which enzyme concentration was held constant, were
carried out. In the ﬁrst experiment the velocity of uninhibitedFigure 9 Lineweaver–Burk plots for compound
Table 2 The kinetic properties of GOT, GPT and c-GT with
compound 7.
Enzymes Kmapp (M) Vmapp (U/L) Ki (M) Type of eﬀect
GOT 100 50 0.0129 Noncompetitive
GPT 400 50 0.02 Noncompetitive
c-GT 1 0.256 0.000263 Noncompetitiveenzyme was established, in the second experimental constant
amount of inhibitor is included in each enzyme assay. Varieties
of substances have the ability to reduce or eliminate the cata-
lytic activity of speciﬁc enzyme (Satyanarayna, 2003).
Table 2 and Fig. 9(a) showed that the type of enzyme acti-
vation using Lineweaver–Burk plot for compound (7) on ser-
um GOT activity. The Vmax and Km values determined with
102 M of compound (7) and without it. Vmax and Km values
without compound (7) were 67 U/L, 200 M respectively. A li-
quate 102 M of compound (7) was noncompetitive activation
for enzyme activity. Noncompetitive activation changed the
Vmax of the enzyme but not the Km. When concentration of
compound was 102 M, the Vmax was 50 M. By using Linewe-
aver–Burk equation, the Ki values of enzyme for compound
which was studied in different concentrations. The Ki of com-
pound (7) in 102 M was 0.0129 M.
Table 2 and Fig. 9(b) show that the type of enzyme activa-
tion using Linweaver and Burke (1934) plot for compound (7)
on serum GPT activity. The Vmax and Km values determined
with 102 M of compound (7) and without it. Vmax and Km
values without compound (7) were 100 U/L, 400 M respec-
tively. A liquate 102 M of compound (7) was noncompetitive
activation for enzyme activity. Noncompetitive activation
changed the Vmax of the enzyme but not the Km. When concen-7 effects on (a) GOT, (b) GPT and (c) GGT.
32 I.H.R. Tomi et al.tration of compound was 102 M, the Vmax was 50 M. By
using Lineweaver–Burk equation, the Ki values of enzyme
for compound which was studied in different concentrations.
The Ki of compound (7) in 10
2 M was 0.02 M.
The enzymes play important role in amino acid metabolism
and in urea and tricarboxylic acid cycles. We suggested that
compound (7) molecule has (N– and O‚) groups by which,
it activities the active sides of amino acids of GOT and GPT
enzymes by increasing afﬁnity of active sides of enzymes to re-
act with the substrates.
Table 2 and Fig. 9(c) show that the type of enzyme inhibitor
using Lineweaver–Burk plot for compound (7) on serum c-GT
activity. The Vmax and Km values determined with 10
2 M of
compound (7) and without it. Vmax and Km values without
compound (7) were 37.037 U/L, 0.4 M respectively. A liquate
102 M of compound (7) was noncompetitive inhibition for en-
zyme activity. Competitive inhibition changed the Km of the
enzyme but not the Vmax. When concentration of compound
was 102 M, the Km was 1 M. By using Lineweaver–Burk
equation, the Ki values of enzyme for compound which was
studied in different concentrations. The Ki of compound (7)
in 102 M was 0.000263 M. Molecule of compound (7) interac-
tion between the groups (N– and O‚) with active sides of ami-
no acids of c-GT enzyme.
4. Conclusion
Bis-1,3,4-oxadiazole compound containing glycine moiety was
prepared and structurally characterized using spectroscopic
techniques. The synthetic route started from esteriﬁcation of
anisic acid followed by reaction the ester with hydrazine hy-
drate. The acid hydrazide was converted to thione–thiol oxadi-
azole tautomer (3) by ring closure mechanism. The thio ester
of oxadiazole (4) was prepared by the reaction of tautomer
(3) with ethyl chloroformate. The acid hydrazide of oxadiazole
(5) was synthesized by the same conditions for prepared com-
pound (2). The compound (7) was prepared by dehydration
mechanism in presence of POCl3. The biochemical studies re-
vealed that the bis-oxadiazole caused activatory effects on
GOT and GPT enzymes activities, and inhibitory effects on
c-GT enzyme activity.Acknowledgment
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